Caredx Total Liab vs Capital Surpluse Analysis
| CDNA Stock | USD 24.11 0.98 4.24% |
Caredx financial indicator trend analysis is way more than just evaluating Caredx Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Caredx Inc is a good investment. Please check the relationship between Caredx Total Liab and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Total Liab vs Capital Surpluse
Total Liab vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Caredx Inc Total Liab account and Capital Surpluse. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Caredx's Total Liab and Capital Surpluse is 0.42. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Caredx Inc, assuming nothing else is changed. The correlation between historical values of Caredx's Total Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Caredx Inc are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Liab i.e., Caredx's Total Liab and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.42 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Capital Surpluse
Most indicators from Caredx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Caredx Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Caredx's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 148.1 K, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 9.6M | 3.8M | 4.3M | 3.7M | Depreciation And Amortization | 11.9M | 16.0M | 19.8M | 20.8M |
Caredx fundamental ratios Correlations
Click cells to compare fundamentals
Caredx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Caredx fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 151.7M | 368.5M | 566.6M | 543.0M | 466.8M | 490.2M | |
| Short Long Term Debt Total | 3.0M | 16.1M | 17.4M | 39.0M | 34.2M | 20.7M | |
| Other Current Liab | 22.6M | 57.5M | 60.0M | 55.1M | 54.5M | 29.1M | |
| Total Current Liabilities | 34.8M | 69.2M | 77.3M | 76.0M | 78.1M | 43.4M | |
| Total Stockholder Equity | 99M | 277.7M | 465.9M | 430.9M | 261.3M | 274.4M | |
| Other Liab | 14.8M | 5.5M | 6.1M | 2.7M | 3.1M | 2.9M | |
| Property Plant And Equipment Net | 9.2M | 25.9M | 40.0M | 70.2M | 65.1M | 68.4M | |
| Current Deferred Revenue | 3.7M | 20.5M | 55.3M | 5.3M | 4.7M | 8.4M | |
| Net Debt | (35.2M) | (118.6M) | (331.1M) | (50.9M) | (48.0M) | (50.4M) | |
| Retained Earnings | (333.8M) | (352.5M) | (383.2M) | (460.4M) | (678.3M) | (644.4M) | |
| Accounts Payable | 5.5M | 9.7M | 13.3M | 9.9M | 12.9M | 13.5M | |
| Cash | 38.2M | 134.7M | 348.5M | 89.9M | 82.2M | 79.7M | |
| Non Current Assets Total | 79.8M | 95.4M | 133.3M | 155.1M | 170.9M | 179.4M | |
| Non Currrent Assets Other | (5.5M) | (9.6M) | (5.7M) | (14.0M) | 19.1M | 20.1M | |
| Other Assets | 1.3M | 1.3M | 6.0M | 4.4M | (17.8M) | (16.9M) | |
| Cash And Short Term Investments | 38.2M | 224.7M | 348.5M | 293.1M | 235.4M | 120.6M | |
| Net Receivables | 24.1M | 34.6M | 59.8M | 66.3M | 51.1M | 53.6M | |
| Common Stock Total Equity | 41K | 42K | 49K | 52K | 59.8K | 62.8K | |
| Common Stock Shares Outstanding | 42.2M | 46.5M | 52.2M | 53.3M | 53.8M | 32.9M | |
| Liabilities And Stockholders Equity | 151.7M | 368.5M | 566.6M | 543.0M | 466.8M | 490.2M | |
| Non Current Liabilities Total | 17.9M | 21.6M | 23.4M | 36.1M | 127.4M | 133.8M | |
| Inventory | 6.0M | 10.0M | 17.2M | 19.2M | 19.5M | 20.4M | |
| Other Current Assets | 3.6M | 7.5M | 15.9M | 9.2M | 7.8M | 4.6M | |
| Other Stockholder Equity | 438.0M | 632.3M | 853.7M | 898.8M | 946.5M | 993.8M | |
| Total Liab | 52.7M | 90.8M | 100.7M | 112.1M | 205.5M | 215.8M | |
| Property Plant And Equipment Gross | 9.2M | 25.9M | 40.0M | 70.2M | 97.4M | 102.3M | |
| Total Current Assets | 71.9M | 273.1M | 433.4M | 387.8M | 313.7M | 329.4M | |
| Accumulated Other Comprehensive Income | (5.2M) | (2.1M) | (4.7M) | (7.5M) | (7.0M) | (7.3M) | |
| Short Term Debt | 3.0M | 2.0M | 4.0M | 5.6M | 5.9M | 4.9M | |
| Common Stock | 29K | 41K | 42K | 49K | 52K | 33.1K | |
| Property Plant Equipment | 9.2M | 25.9M | 40.0M | 70.2M | 80.8M | 84.8M | |
| Net Tangible Assets | 29.6M | 209.5M | 378.7M | 350.3M | 402.9M | 423.0M | |
| Retained Earnings Total Equity | (311.8M) | (333.8M) | (352.5M) | (383.2M) | (344.9M) | (362.1M) | |
| Deferred Long Term Liab | 4.1M | 2.0M | 1.3M | 415K | 373.5K | 354.8K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 5.952 | Quarterly Revenue Growth 0.234 | Return On Assets (0.07) | Return On Equity (0.43) |
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.